Combination of the indoleamine 2,3-dioxygenase 1 inhibitor (IDO1i) BMS-986205 with nivolumab (nivo): Updated safety across all tumors and efficacy in advanced bladder cancer (advBC) by patient (pt) subgroupEuropean Urology Supplements - Tập 18 Số 1 - Trang e1509-e1510 - 2019
Víctor Moreno, Jason J. Luke, Karen A. Gelmon, Anthony M. Joshua, A Varga, Jayesh Desai, B. Markman, Carlos Gomez‐Roca, Filippo de Braud, Shreya Patel, Matteo S. Carlino, Lillian L. Siu, Giuseppe Curigliano, Z. Liu, Yuji Ishii, Megan Wind‐Rotolo, Paul Basciano, Alex Azrilevich, Josep Tabernero